Zai Lab(ZLAB.US)

Event Tracking

Jan6

Zai Lab Receives NMPA Approval for AUGTYRO for NTRK-positive Solid Tumors

12:30

Jan5

Jen-Yao Shin-Yuan Signs Exclusive Licensing Agreement with Zai Lab Taiwan

12:32

Jan2

Zai Lab Official Sells Common Stock

21:19

Dec23

ZailABS COBENFY® Approved by China's National Medical Products Administration

12:30

Dec22

UBS Gives Anzhi Medicine a Buy Rating

02:30

Dec18

Zai Lab Ltd. Chief Legal Officer Reports Common Stock Disposition

21:35

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 116.1 M, Net Income -35.96 M, EPS -0.3263

Zai Lab Limited (ZLAB.US/09688.HK) Q3 2025 Earnings Conference Call

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 109.98 M, Net Income -40.73 M, EPS -0.3729

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 106.49 M, Net Income -48.44 M, EPS -0.4481

Zai Lab Limited (ZLAB.US/09688.HK) Q1 2025 Earnings Conference Call

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change